Close X
Attorney Spotlight

In addition to Mark Manner's busy corporate legal practice, he has established himself as a respected and avid astronomer. Read more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

On December 1, 2016, Parker Hannifin Corporation and CLARCOR Inc. announced that the companies have entered into a definitive agreement under which Parker will acquire CLARCOR for approximately $4.3 billion in cash, including the assumption of net debt. The transaction has been unanimously approved by the board of directors of each company. Upon closing of the transaction, expected to be completed by or during the first quarter of Parker’s fiscal year 2018, CLARCOR will be combined with Parker’s Filtration Group to form a leading and diverse global filtration business. Bass, Berry & Sims has served CLARCOR as primary corporate and securities counsel for 10 years and served as lead counsel on this transaction. Read more here.

CLARCOR
Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Blueprint for an IPO

Companies go public to raise capital to fuel growth, pay down debt and provide liquidity to shareholders. Although all issuers and offerings are different, the basic process of going public remains relatively constant. Blueprint for an IPO identifies the key players, details the process and identifies the obligations companies will face after going public.

Read now

Angela Humphreys Provides Insight on Private Equity Investments in Healthcare Industry

PitchBook News & Analysis

Media Mentions

July 20, 2017

Bass, Berry & Sims attorney Angela Humphreys was featured in a Q&A by PitchBook News & Analysis discussing how private equity investments in the healthcare industry remain undeterred despite fluctuations in the nation's healthcare reform. Throughout the interview, Angela provided answers to questions about the current opportunities, trends and future of private equity investment in healthcare.

Even with the uncertainty surrounding healthcare in the United States, private equity investors still see profitable opportunities in the industry for different reasons. "With healthcare as a necessity and such a large part of the GDP, there continues to be opportunity despite uncertainty in the economic and political climates," Angela noted. However, with a GOP healthcare bill potentially comes a reduction in Medicaid. "The uncertainty around Medicaid likely will result in PE firms taking a harder look at sectors that are more heavily dependent on Medicaid — for example, hospitals and skilled nursing — and factoring that into their deal multiples."

There are certain areas of the healthcare industry that private equity investors find more attractive and where there is more activity, specifically outpatient services. "The hot areas that we are seeing are outpatient services, including physician practice management, specialty pharmacy and any sort of transaction that has as part of its platform technology that drives transparency, quality of outcome and cost efficiency," Angela pointed out.

In terms of the future of investment in the healthcare industry, Angela believes that most firms will wait out the political fluctuation surrounding healthcare. "I think most people are still taking a wait-and-see approach. And there is still a lot of opportunity in the healthcare industry that is somewhat insulated from what may or may not happen with healthcare reform, particularly with companies that can reduce costs, provide transparency, improve quality and outcomes and enhance patient satisfaction."

The full article, "Q&A: PE Firms Keep Backing Booming Healthcare Sector," was published by PitchBook News & Analysis on July 18, 2017, and is available online. The article was republished on the website ValueWalk.com and is also available online. 


Related Professionals

Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.